The present invention concerns a method of treating chronic myelogenous leukemia,
a related myeloproliferative disorder or a Ph-positive acute lymphocytic leukemia
in a subject animal, comprising:
In a preferred embodiment, the animal is a human being.
- (a) selecting or identifying an animal suffering from chronic myelogenous
leukemia or a related myeloproliferative disorder and showing resistance or intolerance
to treatment with STI571; and
- (b) administering to the animal homoharringtonine.